首页|期刊导航|International Journal of Ophthalmology(English edition)|Microglia in retinal vascular diseases:inflammatory mechanism and therapeutic target

Microglia in retinal vascular diseases:inflammatory mechanism and therapeutic targetOA

中文摘要

Retinal vascular diseases(RVDs)are leading causes of vision impairment and blindness,often associated with systemic diseases such as diabetes and hypertension.Despite treatment advancements,managing RVDs,particularly retinal vein occlusion(RVO),remains challenging due to the lack of a definitive cure and reliance on controlling complications.Microglia,the retina’s resident immune cells,play a crucial role in maintaining retinal health,regulating inflammation,and modulating angiogenesis.In pathological conditions,microglia adopt heterogeneous and context-dependent activation states,contributing to both inflammatory injury and vascular repair.Studies suggest that modulating microglial activation and their secreted cytokines may provide novel therapeutic strategies for RVDs.This review examines the role of microglia in RVDs and their potential as therapeutic targets,exploring strategies such as inhibiting microglial activation,regulating pro-angiogenic factor secretion,and targeting specific signaling pathways.Future research should focus on understanding the specific roles of microglial subtypes,their contributions to disease progression,and developing targeted therapies for early diagnosis and treatment of RVDs.

Jing Xu;Hua Yang;Kai-Ming Chen;Meng-Jiao Zhang;Dan Wang;Li-Ke Xie;Xiao-Feng Hao

Department of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,China Postdoctoral Research Station of China Academy of Chinese Medical Sciences,Beijing 100700,ChinaDepartment of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,ChinaDepartment of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,ChinaDepartment of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,ChinaHunan University of Chinese Medicine,Changsha 410007,Hunan Province,ChinaDepartment of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,ChinaDepartment of Fundus Diseases and Ophthalmic Surgery,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,China

医药卫生

retinal vascular diseasesmicrogliainflammationangiogenesis

《International Journal of Ophthalmology(English edition)》 2026 (10)

P.2064-2075,12

Supported by the Central High-Level Traditional Chinese Medicine Hospital Project,Eye Hospital of China Academy of Chinese Medical Sciences(No.GSP5-96,No.GSP5-83,No.GSP5-33,No.GSP4-02-3,No.GSP1-09)the China Postdoctoral Science Foundation(No.2025M784013)National Natural Science Foundation of China(No.82474582).

10.18240/ijo.2026.10.22

评论